Table 3.

Acute effects of benzo[a]pyrene on GPx activity (mean ± SD, n = 10).

Group	Time	Liver	Lung	Kidney	Stomach	Brain
Control	24	80.33 ± 9.71	44.55 ± 5.63	56.74 ± 6.42	44.13 ± 4.76	44.22 ± 6.47
12.5 mg/kg	24	83.06 ± 8.99	49.06 ± 5.08	61.58 ± 8.67	47.22 ± 4.57	46.69 ± 4.31
25 mg/kg	24	85.06 ± 9.12	52.96 ± 5.13a	62.92 ± 14.31	50.91 ± 4.14a	50.03 ± 4.84
50 mg/kg	24	88.97 ± 11.36	56.68 ± 7.28b	63.52 ± 11.57	53.52 ± 6.07b	62.28 ± 7.49c
100 mg/kg	24	92.48 ± 11.35a	60.11 ± 6.32c	65.41 ± 11.81	58.21 ± 6.86c	65.72 ± 7.42c
Control	48	82.11 ± 9.65	45.35 ± 5.52	57.65 ± 6.12	44.62 ± 4.75	44.75 ± 6.32
12.5 mg/kg	48	87.44 ± 11.70	52.34 ± 5.54a	63.44 ± 9.14	49.91 ± 4.72a	49.81 ± 5.59
25 mg/kg	48	90.44 ± 12.45	54.98 ± 6.56b	65.42 ± 12.03	52.48 ± 5.43b	56.67 ± 5.85c
50 mg/kg	48	91.90 ± 12.23	59.39 ± 6.74c	66.81 ± 12.44	56.75 ± 6.52c	65.54 ± 8.28c
100 mg/kg	48	95.83 ± 12.81a	65.42 ± 7.11c	68.2 ± 12.52a	61.32 ± 7.11c	68.37 ± 7.23c
Control	72	84.25 ± 9.39	46.52 ± 5.19	59.17 ± 6.38	45.38 ± 4.53	45.37 ± 6.21
12.5 mg/kg	72	90.12 ± 12.25	51.98 ± 4.75b	65.63 ± 7.12a	51.19 ± 5.93b	55.03 ± 4.42c
25 mg/kg	72	93.12 ± 13.14	56.18 ± 7.36c	67.45 ± 8.32a	54.49 ± 5.59c	63.56 ± 5.88c
50 mg/kg	72	96.62 ± 15.43a	62.88 ± 7.33c	69.43 ± 8.10b	59.35 ± 6.61c	67.30 ± 5.92c
100 mg/kg	72	98.92 ± 15.56a	68.16 ± 5.63c	71.28 ± 11.39b	65.42 ± 6.82c	76.33 ± 7.21c

^aP < 0.05.

^bP < 0.01.

^cP < 0.001 between the corresponding control and B[a]P treatment groups, respectively.